Mary Mosher

Array ( [id] => 4232243 [patent_doc_number] => 06074816 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 8/307273 [patent_app_country] => US [patent_app_date] => 1994-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 168 [patent_figures_cnt] => 91 [patent_no_of_words] => 72904 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074816.pdf [firstpage_image] =>[orig_patent_app_number] => 307273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221396 [patent_doc_number] => 06010887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Regulation of gene expression' [patent_app_type] => 1 [patent_app_number] => 8/305741 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6594 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010887.pdf [firstpage_image] =>[orig_patent_app_number] => 305741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725181 [patent_doc_number] => 05651972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Use of recombinant swine poxvirus as a live vaccine vector' [patent_app_type] => 1 [patent_app_number] => 8/307499 [patent_app_country] => US [patent_app_date] => 1994-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17584 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/651/05651972.pdf [firstpage_image] =>[orig_patent_app_number] => 307499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528939 [patent_doc_number] => 05583028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-10 [patent_title] => 'Recombinant vaccinia virus as DNA constructs encoding HSV glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/306259 [patent_app_country] => US [patent_app_date] => 1994-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 51 [patent_no_of_words] => 33695 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/583/05583028.pdf [firstpage_image] =>[orig_patent_app_number] => 306259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3617276 [patent_doc_number] => 05641490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Infectious bursal disease virus recombinant poxvirus vaccine' [patent_app_type] => 1 [patent_app_number] => 8/303124 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10251 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641490.pdf [firstpage_image] =>[orig_patent_app_number] => 303124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689111 [patent_doc_number] => 05663317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Microorganism having attenuated invasiveness' [patent_app_type] => 1 [patent_app_number] => 8/295760 [patent_app_country] => US [patent_app_date] => 1994-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7990 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663317.pdf [firstpage_image] =>[orig_patent_app_number] => 295760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244504 [patent_doc_number] => 06207161 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Induction of cytolytic T-lymphocytes with cytomegalovirus polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/256104 [patent_app_country] => US [patent_app_date] => 1994-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5122 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207161.pdf [firstpage_image] =>[orig_patent_app_number] => 256104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768512 [patent_doc_number] => 05807557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Soluble herpesvirus glycoprotein complex' [patent_app_type] => 1 [patent_app_number] => 8/280442 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7308 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807557.pdf [firstpage_image] =>[orig_patent_app_number] => 280442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126052 [patent_doc_number] => 06120773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Recombinant herpes simplex viruses vaccines and methods' [patent_app_type] => 1 [patent_app_number] => 8/272772 [patent_app_country] => US [patent_app_date] => 1994-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 7 [patent_no_of_words] => 11388 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/120/06120773.pdf [firstpage_image] =>[orig_patent_app_number] => 272772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3595198 [patent_doc_number] => 05558867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Recombinant Marek\'s disease virus, process for preparing the same and vaccine containing the same' [patent_app_type] => 1 [patent_app_number] => 8/272513 [patent_app_country] => US [patent_app_date] => 1994-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 9770 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/558/05558867.pdf [firstpage_image] =>[orig_patent_app_number] => 272513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700236 [patent_doc_number] => 05674709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Pseudorabies virus protein' [patent_app_type] => 1 [patent_app_number] => 8/262813 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10400 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674709.pdf [firstpage_image] =>[orig_patent_app_number] => 262813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 816839 [patent_doc_number] => 07410646 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-08-12 [patent_title] => 'Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine' [patent_app_type] => utility [patent_app_number] => 08/261692 [patent_app_country] => US [patent_app_date] => 1994-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6567 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410646.pdf [firstpage_image] =>[orig_patent_app_number] => 08261692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208406 [patent_doc_number] => 06713072 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine' [patent_app_type] => B1 [patent_app_number] => 08/261668 [patent_app_country] => US [patent_app_date] => 1994-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6533 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713072.pdf [firstpage_image] =>[orig_patent_app_number] => 08261668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756784 [patent_doc_number] => 05741490 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Hepatitis E virus vaccine and method' [patent_app_type] => 1 [patent_app_number] => 8/259148 [patent_app_country] => US [patent_app_date] => 1994-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 14092 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741490.pdf [firstpage_image] =>[orig_patent_app_number] => 259148 [rel_patent_id] =>[rel_patent_doc_number] =>)